FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while ...
In "Shared Decision-Making for Agitation in Specialty Care and Disease Trajectory," our experts close out the discussion of ...
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for ...
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication ...
A multicomponent approach to vaccination distress works across the lifespan, though how it works depends on age, according to ...
Many patients with atrial fibrillation (AFib) are not receiving any therapy to prevent stroke, and Geoffrey Barnes, MD, ...
The faculty compare testing strategies across clinical and pharmacy settings. This episode, "HIV Testing Before and During PrEP: Getting It Right," features the faculty walking through baseline and ...
Eli Lilly announced that the FDA has expanded the US approval of baricitinib (Olumiant) to include patients aged 12 years and ...
"Starting the HIV PrEP Conversation in Primary Care and Pharmacy" takes up the question of how clinicians and pharmacists can start the PrEP conversation, and who should be having it.
Managing a patient’s pain and fear during vaccination is not a courtesy but an expected part of care, argues Anna Taddio, PhD, a professor at the University of Toronto and lead ...
EASD 2026: The combination of semaglutide/cagrilintide altered food-cue responses and showed a 22.4% estimated weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results